Psychiatric disorders are a major public health concern. While the development of neuroleptics and antidepressants has led to significant improvements in patients’ conditions, available treatments remain largely insufficient and unsatisfactory. Advances in the field are hindered by a shortage of tools to conduct adequate biological measurements that can then guide diagnosis and treatment.